Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04898114
PHASE1/PHASE2

Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn

Sponsor: Sohag University

View on ClinicalTrials.gov

Summary

The aim of this study is to evaluate the effectiveness of nebulized magnesium sulfate combined with sildenafil citrate, compared with sildenafil citrate alone, in treating neonates with severe persistent pulmonary hypertension on mechanical ventilation.

Official title: Effectiveness of Nebulized Magnesium Sulfate Combined With Sildenafil Citrate in Persistent Pulmonary Hypertension of Newborn

Key Details

Gender

All

Age Range

6 Hours - 72 Hours

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2021-06-02

Completion Date

2025-06-01

Last Updated

2024-11-27

Healthy Volunteers

No

Interventions

DRUG

Magnesium sulfate

Nebulized magnesium sulfate (4 ml of 6.4% solution) every 15 minutes

DRUG

Sildenafil Citrate

Oral sildenafil citrate at an initial dose of 1 mg/kg, with incremental increases by 0.5 mg/kg every 6 hours till reaching a target dose of 2mg/kg every 6 hours.

OTHER

Isotonic saline

Nebulized isotonic saline (4 ml) every 15 minutes

Locations (1)

Neonatal Intensive Care Unit, Sohag University Hospital

Sohag, Egypt